Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. (Q50066983)
Jump to navigation
Jump to search
scientific article published on 12 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. |
scientific article published on 12 February 2018 |
Statements
1 reference
Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. (English)
1 reference
Martha M Moore
1 reference
Rita S Schoeny
1 reference
Richard A Becker
1 reference
Kimberly White
1 reference
Lynn H Pottenger
1 reference
12 February 2018
1 reference
1 reference
1-26
1 reference
Identifiers
1 reference
1 reference